Related Drugs
Chymotrypsin for injection
Indication: It is a proteolytic enzyme that has the function of decomposing peptide chains. It can clean suppurative wounds, dissolve pus and necrotic tissue, promote the growth of granulation tissue, and selectively loosen the ciliary ligament. It can be used in combination with antibiotics and sulfonamides to treat various inflammations, ulcers, abscesses, hematomas, empyema, otitis media, and cataract removal.
Manufacturer:
Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.
Clindamycin Hydrochloride Capsules
Indication: This product is suitable for the following infections caused by sensitive strains of Streptococcus, Staphylococcus and anaerobic bacteria: otitis media, sinusitis, suppurative tonsillitis, pneumonia; skin and soft tissue infections; in the treatment of bone and joint infections, abdominal infections, pelvic infections, empyema, lung abscess, osteomyelitis, sepsis and other diseases, it can be used alone or in combination with other antibacterial drugs according to the situation.
Manufacturer:
Sichuan Meidakang Pharmaceutical Co., Ltd.
Clindamycin Hydrochloride Capsules
Indication: This product is suitable for the following infections caused by sensitive strains of Streptococcus, Staphylococcus and anaerobic bacteria: otitis media, sinusitis, suppurative tonsillitis, pneumonia; skin and soft tissue infections; in the treatment of bone and joint infections, abdominal infections, pelvic infections, empyema, lung abscess, osteomyelitis, sepsis and other diseases, it can be used alone or in combination with other antibacterial drugs according to the situation.
Manufacturer:
Anhui Renhe Pharmaceutical Co., Ltd.
Clindamycin Hydrochloride Capsules
Indication: This product is suitable for the following infections caused by sensitive strains of Streptococcus, Staphylococcus and anaerobic bacteria: otitis media, sinusitis, suppurative tonsillitis, pneumonia; skin and soft tissue infections; in the treatment of bone and joint infections, abdominal infections, pelvic infections, empyema, lung abscess, osteomyelitis, sepsis and other diseases, it can be used alone or in combination with other antibacterial drugs according to the situation.
Manufacturer:
Zhejiang Yatai Pharmaceutical Co., Ltd.
Cefmetazole Sodium for Injection
Indication: This product is suitable for the treatment of the following infections caused by Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus, Morganella morganii, Providencia, Peptostreptococcus, Bacteroides, Prevotella (except Prevotella biloba) that are sensitive to cefmetazole sodium: 1. Sepsis 2. Acute bronchitis, pneumonia, lung abscess, empyema, secondary infection of chronic respiratory diseases 3. Cystitis, pyelonephritis 4. Peritonitis 5. Cholecystitis, cholangitis 6. Bartholinitis, intrauterine infection, adnexitis, parametritis 7. Cellulitis around the jaws, jaw inflammation In the clinical studies (including double-blind trials) of 2,819 cases of intravenous injection, intravenous drip and intramuscular injection in 137 hospitals in Japan, the clinical results of 1,409 cases that can be judged as effective and belong to the approved indications of this product are as follows (for refractory or severe infections, the daily dose is increased to 4 grams (potency) for adults and 150 mg (potency) for children according to symptoms)/kg body weight): 1. Sepsis: The total effective rate for sepsis caused by Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae is 80.6% (25/31), and the dosage is 2-4g per day for adults and 50-150mg/kg for children. 2. Respiratory system infection: The total effective rate for respiratory tract infection caused by Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus, Morganella morganii, Providencia, etc. is 79.7% (267/335). The dosage for drip or intravenous injection is 2-4g per day. In the double-blind trial, the efficacy of this product has been verified. 3. Biliary tract infection: This product is well excreted into bile and can reach a high concentration in bile. The total effective rate for cholecystitis and cholangitis caused by Escherichia coli and Klebsiella pneumoniae is 83.1% (49/59). The dosage is 2~4g per day. 4. Peritonitis: The total effective rate for peritonitis caused by Escherichia coli, Klebsiella pneumoniae, Bacteroides, Prevotella (except Prevotella biloba), etc. is 87.596 (161/184). Most of them are intravenous drips, and the dosage is 2~4g per day. 5. Urinary tract infection: The total effective rate for cystitis and pyelonephritis caused by Escherichia coli, Klebsiella pneumoniae, Proteus, Morganella kurschniki, Providencia, etc. is 73.1% (302/413). The dosage is mostly 1~2g per day. The results of a double-blind controlled trial on chronic complicated urinary tract infections have proved the efficacy of this product. 6. Gynecology and Obstetrics: The total effective rate for vestibular glanditis, intrauterine infection, adnexitis, and parametrial tissue inflammation caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Peptostreptococcus, Bacteroides, and Prevotella (except Prevotella biloba) is 94.796 (232/245). The dosage is usually 2-4g per day. 7. Oral Surgery: The total effective rate for perimandibular cellulitis and jaw inflammation caused by Peptostreptococcus is 83.896 (119/142). The dosage is usually 2-4g per day.
Clindamycin Phosphate Injection
Indication: 1. This product is suitable for the following infectious diseases caused by Gram-positive bacteria: 1), tonsillitis, suppurative otitis media, sinusitis, etc. 2), acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined with infection, etc. 3), skin and soft tissue infections: furuncle, carbuncle, abscess, cellulitis, trauma and postoperative infection, etc. 4), urinary system infection: acute urethritis, acute pyelonephritis, prostatitis, etc. 5), others: osteomyelitis, sepsis, peritonitis and oral infection, etc. 2. This product is suitable for various infectious diseases caused by anaerobic bacteria: 1), empyema, lung abscess, lung infection caused by anaerobic bacteria. 2), skin and soft tissue infection, sepsis. 3), intra-abdominal infection: peritonitis, peritoneal
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Clindamycin Phosphate Injection
Indication: 1. This product is suitable for the following infectious diseases caused by Gram-positive bacteria: 1), tonsillitis, suppurative otitis media, sinusitis, etc. 2), acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined with infection, etc. 3), skin and soft tissue infections: furuncle, carbuncle, abscess, cellulitis, trauma and postoperative infection, etc. 4), urinary system infection: acute urethritis, acute pyelonephritis, prostatitis, etc. 5), others: osteomyelitis, sepsis, peritonitis and oral infection, etc. 2. This product is suitable for various infectious diseases caused by anaerobic bacteria: 1), empyema, lung abscess, lung infection caused by anaerobic bacteria. 2), skin and soft tissue infection, sepsis. 3), intra-abdominal infection: peritonitis,
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Clindamycin Hydrochloride Injection
Indication: This product is suitable for moderate and severe infections caused by Streptococcus, Staphylococcus and anaerobic bacteria (including Bacteroides fragilis, Clostridium perfringens, Actinomycetes, etc.), such as aspiration pneumonia, empyema, lung abscess, osteomyelitis, abdominal infection, pelvic infection and sepsis.
Manufacturer:
Chongqing Lummy Pharmaceutical Co., Ltd.